Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy

AA Hagège, C Carrion, P Menasché, JT Vilquin… - The Lancet, 2003 - thelancet.com
AA Hagège, C Carrion, P Menasché, JT Vilquin, D Duboc, JP Marolleau, M Desnos…
The Lancet, 2003thelancet.com
Autologous skeletal myoblast transplantation might improve postinfarction ventricular
function, but graft viability and differentiation (ie, proof of concept) has not been shown. A 72-
year-old man had autologous cultured myoblasts from his vastus lateralis injected to an area
of transmural inferior myocardial infarction in non-reperfused scar tissue. He showed
improvement in symptoms and left-ventricular ejection fraction. When he died 17· 5 months
after the procedure, the grafted post-infarction scar showed well developed skeletal …
Summary
Autologous skeletal myoblast transplantation might improve postinfarction ventricular function, but graft viability and differentiation (ie, proof of concept) has not been shown. A 72-year-old man had autologous cultured myoblasts from his vastus lateralis injected to an area of transmural inferior myocardial infarction in non-reperfused scar tissue. He showed improvement in symptoms and left-ventricular ejection fraction. When he died 17·5 months after the procedure, the grafted post-infarction scar showed well developed skeletal myotubes with a preserved contractile apparatus. 65% of myotubes expressed the slow myosin isoform and 33% coexpressed the slow and fast isoforms (vs 44% and 0·6%, respectively, in skeletal muscle). Myoblast grafts can survive and show a switch to slow-twitch fibres, which might allow sustained improvement in cardiac function.
thelancet.com